Clovis Oncology Inc (OTC Pink - Limited Information:CLVSQ)
| 0.03 Delayed Data As of Jun 06 |  +0.0019 / +6.76%Today’s Change | 0.01 Today|||52-Week Range 3.25 | -43.13% Year-to-Date |
Latest CLVSQ News | Press Releases
No recent news for Clovis Oncology Inc.
Today’s Trading
| Previous close | 0.03 |
| Today’s open | 0.03 |
| Day’s range | 0.03 - 0.03 |
| Volume | 166,645 |
| Average volume (3 months) | 684,767 |
| Market cap | $4.5M |
Data as of 06/06/2023
Growth & Valuation
| Earnings growth (last year) | +47.72% |
| Earnings growth (this year) | +32.70% |
| Earnings growth (next 5 years) | +27.85% |
| Revenue growth (last year) | -9.58% |
| P/E ratio | -- |
| Price/Sales | 2.10 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | November 2, 2022 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $148.8M |
| Annual profit (last year) | -$264.5M |
| Net profit margin | -177.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
Chart unavailable
